Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus
Keywords: Conditionally replicating adenovirus; Apoptin; Human telomerase reverse transcriptase; Safety evaluation;